FDA 483 - Houston Fertility Center - December 30, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
This FDA Form 483 report details significant deficiencies at Houston Fertility Center related to the processing and handling of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). The firm failed to properly screen donors for communicable diseases, maintain adequate records, and ensure appropriate labeling for HCT/Ps, including those from ineligible donors. These issues indicate a lack of robust procedures and adherence to regulations concerning donor eligibility and product safety.
ID · 2e8d7048-3562-4d6b-b9f2-4c703c870c6f